Mesoblast Limited
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MSB.AX | SLDB | VCEL | LCTX | BEAM | GERN | |
|---|---|---|---|---|---|---|
| Market cap | 2.30B | 592.96M | 2.05B | 247.42M | 2.42B | 751.69M |
| P/E (TTM) | — | — | 85.4 | — | — | — |
| Forward P/E | -63.8 | -3.2 | 47.4 | -7.1 | -5.0 | 29.3 |
| Price/book | 2.8 | 1.6 | 5.5 | 4.1 | 2.2 | 3.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −25.19% | −10.08% | +11.41% | −40.24% | −23.35% | −7.87% |
| Today | −11.06% | −3.66% | −2.17% | −1.21% | −5.10% | −4.88% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All MSB.AX news ›Buy, hold, sell: Mesoblast, PLS, and SEEK shares
Bell Potter has given its verdict on these shares this week. If you are in the market for some new portfolio additions, it could be worth seeing what the team at Bell Potter is saying about the three ASX shares in this article. Does the…
Mesoblast Reports Strong Q1 FY26 with Soaring Ryoncil® Revenue and Improved Cash Position
Mesoblast Limited (ASX:MSB), a global leader in allogeneic cellular medicines for inflammatory diseases, develops off-the-shelf cellular therapies designed to counter and modulate severe inflammation. The company today reported a…
Mesoblast preliminary Q1 Ryoncil revenue rises 44%
Preliminary net operational cash spend improves 85% as Mesoblast (MESO) posts Ryoncil revenue growth. Stock Titan Mesoblast preliminary Q1 Ryoncil revenue rises 44% September brought Mesoblast’s highest monthly count of new patient starts…
Mesoblast submits three ASX securities notices
The notices cover securities cessation; issue, conversion or payment up of unquoted equity; and an application for securities quotation. Mesoblast submits three ASX securities notices Sentiment and the balance of points Rhea-AI Sentiment…
Why did Mesoblast (ASX:MSB) get a fresh FDA nod on quality?
Glencore (ASX:GLC) ASX Debut: What the New Listing Means A potency assay is a laboratory test that confirms a medicine has the biological activity it is supposed to have. For conventional chemical drugs, this can be relatively…
From US$17.2M a year earlier, FY2026 revenue climbs at Mesoblast (MESO).
Travelan® Phase 2 Study Results Published UnitedHealth Group Reports Third Quarter 2026 Results The adult SR-aGvHD trial is enrolling, while the low-back-pain Phase 3 trial completed treatment of 350 patients. Mesoblast Limited reported…
Mesoblast (NASDAQ:MESO) Stock Price Breaks Below 50 Day Moving Average – Should You Sell?
Posted by Defense World Staff on Oct 13th, 2026 Mesoblast Limited (NASDAQ:MESO – Get Free Report)’s stock price crossed below its 50 day moving average during trading on Monday. The stock has a 50 day moving average of $15.78 and traded as…
Which ASX Penny Stocks Are Worth Watching in October 2026, Including Mesoblast (ASX:MSB)?
What Is Weighing on Worley (ASX:WOR) Despite a Fatter Backlog? Why Is Arena REIT (ASX:ARF) Rallying on the Edge Sale? How Are Bond Yields Weighing on Atlas Arteria (ASX:ALX)? How Would an Austal USA Sale Reshape Austal (ASX:ASB)? Mesoblast…
What Are Brokers Saying About Mesoblast (ASX:MSB), Dicker Data (ASX:DDR) and ASX Limited (ASX:ASX)?
Are Copper-Zinc Prices Opening a Door for Anax (ASX:ANX)? Why Did TPG Telecom (ASX:TPG) Slide on SpaceX Spectrum News? How Does IperionX (ASX:IPX) Plan a US Titanium Listing Shift? What Lifted Sandfire (ASX:SFR) as Copper Miners Rallied?…
Buy, hold, sell: Mesoblast, Transurban, NextDC shares
The market has started the new week in the green. S&P/ASX 200 Index (ASX: XJO) shares are up 0.4% to 8,749.7 points on Monday. Among the 11 market sectors, information technology is in the lead today, up 2.3%. The consumer staples sector…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
kalkinemedia.com6
-
stocktitan.net4
-
fool.com.au2
-
defenseworld.net1
-
sharecafe.com.au1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 14 articles, not a forecast.